{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":43,"n_cols":5,"rows_kept":43,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[10,2,10,3],[11,2,11,3],[17,2,17,3],[17,4,17,5],[18,2,18,3],[18,4,18,5],[19,2,19,3],[21,2,21,3],[24,2,24,3],[25,2,25,3],[26,2,26,3],[27,2,27,3],[28,2,28,3],[30,2,30,3],[34,2,34,3],[35,2,35,3],[39,2,39,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA996393533203316"]
[null,null,"Autore",null,"Sandys George <1578-1644.>"]
[null,null,"Titolo",null,"Sandys travels [[electronic resource] ] : containing an history of the original and present state of the Turkish Empire, their laws, government, policy, military force, courts of justice, and commerce, the Mahometan religion and ceremonies, a description of Constantinople, the Grand Signior's seraglio, and his manner of living : also, of Greece, with the religion and customs of the Grecians ; Of Ægypt, the antiquity, hieroglyphicks, rites, customs, discipline, and religion of the Ægyptians ; A voyage on the River Nylvs ; Of Armenia, Grand Cairo, Rhodes, the Pyramides, Colossus, the former flourishing and present state of Alexandria ; A description of the Holy-Land, of the Jews, and several sects of Christians living there ; Of Jerusalem, sepulchre of Christ, Temple of Solomon, and what else either of antiquity, or worth observation ; Lastly, Italy described, and the islands adjoyning, as Cyprus, Crete, Malta, Sicilia, the Æolian Islands, of Rome, Venice, Naples, Syracusa, Mesena, Ætna, Scylla and Charybdis, and other places of note : illustrated with fifty graven maps and figures"]
[null,null,"Pubbl/distr/stampa",null,"London, : Printed for Rob. Clavel, Tho. Passinger, Will Cadman, Tho. Sawbridge, and Will Birch, 1670"]
[null,null,"Edizione",null,"[The seventh edition.]"]
[null,null,"Descrizione fisica",null,"[7], 240 p. : ill., maps (1 folded)"]
[null,null,"Soggetti",null,"Voyages and travels"]
[{"$nulls":4},"Middle East Description and travel"]
[{"$nulls":4},"Italy Description and travel"]
[{"$nulls":4},"Italy Description and travel Early works to 1800"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Includes bibliographical references."]
[{"$nulls":4},"Added engraved t.p.: A relation of a iourney begun an: Dom: 1610. Fovre bookes. Containing a description of the Turkish empire, of AEgypt, of the Holy Land of the remote parts of Italy, and ilands adjoyning. The 6th edition. London : Printed for Philip Chetwin, 1670."]
[{"$nulls":4},"Reproduction of original in Duke University Library."]
[null,null,null,"Sommario/riassunto","eebo-0113"]
[null,"2.","Record Nr.",null,"UNINA9910959037503321"]
[null,null,"Titolo",null,"Clinical and statistical considerations in personalized medicine / / edited by Claudio Carini, Pfizer, Cambridge, Massachusetts, USA, Sandeep M. Menon, Pfizer, Cambridge, Massachusetts, USA, Mark Chang, AMAG Pharmaceuticals, Incorporated Waltham, Massach"]
[null,null,"Pubbl/distr/stampa",null,"Boca Raton : , : CRC Press, , [2014]"]
[{"$nulls":4},"©2014"]
[null,null,"ISBN",null,"1-04-021213-1"]
[{"$nulls":4},"0-429-16933-7"]
[{"$nulls":4},"1-4665-9387-3"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (368 p.)"]
[null,null,"Collana",null,"Chapman and Hall/CRC Biostatistics Series"]
[null,null,"Classificazione",null,"MAT029000MED045000MED071000"]
[null,null,"Disciplina",null,"615.7072/7"]
[{"$nulls":4},"615.70727"]
[null,null,"Soggetti",null,"Pharmacogenetics - Mathematical models"]
[{"$nulls":4},"Pharmacogenetics - Statistical methods"]
[{"$nulls":4},"Pharmacogenomics - Mathematical models"]
[{"$nulls":4},"Pharmacogenomics - Statistical methods"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"Front Cover; Contents; Preface; Editors; Contributors; Chapter 1: Biomarkers for Drug Development: The Time Is Now!; Chapter 2: RNAi Screens: Triumphs and Tribulations; Chapter 3: Current Advances in Epigenetics; Chapter 4: Biomarkers and Precision Medicine: The Case of Rare Diseases; Chapter 5: Biomarker-Informed Adaptive Design; Chapter 6: Fitting the Dose: Adaptive Staggered Dose Design; Chapter 7: Evidence-Based Adaptive Statistical Decision and Design Strategies for; Chapter 8: Biomarker Identification in Clinical Trials; Chapter 9: Multiplicity in Pharmacogenomics"]
[{"$nulls":4},"Chapter 10: Patient-Reported Outcomes in Personalized MedicineChapter 11: Regulatory Issues in Use of Biomarkers in Drug Development; Back Cover"]
[null,null,null,"Sommario/riassunto","Personalized medicine has the potential to change the way we think about, identify, and manage health problems. In the pharmaceutical industry, it is already having an exciting impact on both clinical research and patient care. This impact will continue to grow as our "]
[{"$nulls":4},"understanding and technologies improve. With contributions from well-known industry leaders in clinical development, this book covers the practical aspects of personalized medicine, focusing on issues that have direct application in the industry. Topics include designs for targeted therapy, adaptive designs, evidence-based adaptive statistical decisions, and design strategies for maximizing the efficiency of clinical oncology--"]